Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas.

Literature DB >> 12672037

Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas.

Anthony P Polednak¹.

Abstract

Entities: Disease

Mesh：

Year: 2003 PMID： 12672037 DOI： 10.1002/ijc.11029

Source DB: PubMed Journal: Int J Cancer ISSN： 0020-7136 Impact factor: 7.396

Keyword Cloud
Cited

× No keyword cloud information.

75 in total

Review 1. Vitamin D and Gastrointestinal Cancers: A Narrative Review.

Authors: Hemant Goyal; Abhilash Perisetti; M Rubayat Rahman; Avi Levin; Giuseppe Lippi
Journal: Dig Dis Sci Date: 2018-12-03 Impact factor: 3.199

2. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus.

Authors: Tong Chen; Fei Yan; Jiaming Qian; Mingzhou Guo; Hongbing Zhang; Xiaofei Tang; Fang Chen; Gary D Stoner; Xiaomin Wang
Journal: Cancer Prev Res (Phila) Date: 2011-12-01

3. TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort.

Authors: L Murray; A Sedo; M Scott; D McManus; J M Sloan; L J Hardie; D Forman; C P Wild
Journal: Gut Date: 2006-05-08 Impact factor: 23.059

4. The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort.

Authors: B T Theron; H Padmanabhan; H Aladin; P Smith; E Campbell; P Nightingale; B T Cooper; N J Trudgill
Journal: United European Gastroenterol J Date: 2016-02-19 Impact factor: 4.623

5. A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus.

Authors: John M Poneros; Adam S Faye; Emily G Barr Fritcher; Ananda Sen; Sharmila Anandasabapathy; Robert S Bresalier; Norman Marcon; D Kim Turgeon; Henry Appelman; Daniel Normolle; Larry E Morrison; Dean E Brenner; Kevin C Halling
Journal: Dig Dis Sci Date: 2017-03-06 Impact factor: 3.199

10. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.

Authors: S Guan; B Liu; C Zhang; K-H Lee; S Sun; J Wei
Journal: Clin Transl Oncol Date: 2013-02-20 Impact factor: 3.405

Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas.

Review 1. Vitamin D and Gastrointestinal Cancers: A Narrative Review.

2. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus.

3. TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort.

4. The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort.

5. A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus.

Review 6. Ablative therapies for Barrett's esophagus.

7. Isolated bony metastasis to upper limb from carcinoma of the oesophagus: report of three cases.

8. Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma.

Review 9. Chemoprevention of esophageal squamous cell carcinoma.

10. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.